Legend Co-Leads $38M Round In Chinese Medical CRO Firm Bellen
September 22, 2017 — 12:18 CST
This Data Is Locked!
This area is available only to Subscribers.
Legend Capital and Zhongjinqichen, a healthcare, technology and consumer-focused private equity fund under China International Capital Co., Ltd have lead a RMB250 million (US$38 million)... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals